p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma

被引:1
|
作者
Li, Pei-Hua [1 ]
Cao, Wen-Jia [3 ]
Mao, Lin-Lin [3 ]
Huang, Hui [3 ]
Zheng, Jun-Nian [2 ,3 ]
Pei, Dong-Sheng [3 ]
机构
[1] Xuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
[2] Xuzhou Med Coll, Affiliated Hosp, Ctr Clin Oncol, Xuzhou 221002, Peoples R China
[3] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R China
基金
中国国家自然科学基金;
关键词
p42.3; RCC; cell invasion; E-cadherin; beta-catenin; EPITHELIAL-MESENCHYMAL TRANSITIONS; ADHESION MOLECULES; COLORECTAL-CANCER; PROGRESSION; CADHERINS; ACTIVATION; MECHANISMS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
p42.3 is a tumor-specific gene and found to be over-expressed in many tumor cell lines and primary tumor tissues. It plays a significant role in neoplastic transformation and tumor progression. To date, the association between p42.3 and Renal-Cell Carcinoma (RCC) has not been reported. This study investigated the biological effects and mechanisms of p42.3 in RCC progression. In this study, we found that p42.3 is overexpressed in various kinds of RCC cells, and knockdown of p42.3 dramatically reduced cell proliferation and invasion in vitro. Our studies revealed that overexpression of p42.3 accelerates the epithelial-mesenchymal transition (EMT) progression and induces RCC cells proliferation and invasion. Further studies show that p42.3 may involve in activation of beta-catenin and participate in RCC cell invasion. Combined, these data indicate that p42.3 contributes to promoting RCC cells proliferation and invasion through accelerates the EMT progression and beta-catenin activation.
引用
收藏
页码:4959 / 4966
页数:8
相关论文
共 50 条
  • [31] RENAL-CELL CARCINOMA
    不详
    LANCET, 1976, 2 (7991): : 887 - 888
  • [32] EMMPRIN PROMOTES ANGIOGENESIS, PROLIFERATION AND INVASION OF RENAL CELL CARCINOMA AND BE A PREDICTOR OF PATIENT OUTCOME
    Sato, Mototaka
    Nakai, Yasutomo
    Nakata, Wataru
    Yoshida, Takahiro
    Hatano, Koji
    Fujita, Kazutoshi
    Uemura, Motohide
    Takayama, Hitoshi
    Nonomura, Norio
    JOURNAL OF UROLOGY, 2013, 189 (04): : E120 - E120
  • [33] CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
    Zhang, Yongzhen
    Fang, Liang
    Zang, Yuanwei
    Ren, Juchao
    Xu, Zhonghua
    JOURNAL OF CANCER, 2018, 9 (21): : 4029 - 4038
  • [34] RENAL-CELL CARCINOMA
    HALPERN, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1964, 270 (02): : 108 - &
  • [35] RENAL-CELL CARCINOMA
    JONAS, U
    ANTON, P
    WORLD JOURNAL OF UROLOGY, 1995, 13 (03) : 137 - 137
  • [36] RENAL-CELL CARCINOMA
    LINEHAN, WM
    JOURNAL OF UROLOGY, 1988, 139 (02): : 340 - 341
  • [37] RENAL-CELL CARCINOMA
    KREEL, L
    POSTGRADUATE MEDICAL JOURNAL, 1986, 62 (730) : 737 - 740
  • [38] RENAL-CELL CARCINOMA
    MARSHALL, FF
    JOURNAL OF UROLOGY, 1982, 128 (05): : 923 - 923
  • [39] Renal-cell carcinoma
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2009, 5 : C1 - C2
  • [40] p42.3 in Gastric Carcinoma: A Novel Biomarker and Promising Therapeutic Target
    Jing, Hui
    Wei, Lu-Lu
    Huo, Fu-Chun
    Ren, Xin
    Zheng, Jun-Nian
    Pei, Dong-Sheng
    LETTERS IN DRUG DESIGN & DISCOVERY, 2017, 14 (10) : 1221 - 1225